世界の肺胞蛋白症（PAP）市場：市場規模・現状・予測

• 英文タイトル：Global Pulmonary Alveolar Proteinosis (PAP) Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7907
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、肺胞蛋白症（PAP）のグローバル市場について調査・分析したレポートで、種類別（血漿交換、肺移植、その他）、用途別（病院、外来手術センター、診断センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・肺胞蛋白症（PAP）の世界市場規模
・主要企業別市場シェア
・肺胞蛋白症（PAP）の世界市場規模：種類別（血漿交換、肺移植、その他）
・肺胞蛋白症（PAP）の世界市場規模：用途別（病院、外来手術センター、診断センター）
・肺胞蛋白症（PAP）のアメリカ市場規模（種類別、用途別）
・肺胞蛋白症（PAP）のヨーロッパ市場規模（種類別、用途別）
・肺胞蛋白症（PAP）の中国市場規模（種類別、用途別）
・肺胞蛋白症（PAP）の日本市場規模（種類別、用途別）
・肺胞蛋白症（PAP）の東南アジア市場規模（種類別、用途別）
・肺胞蛋白症（PAP）のインド市場規模（種類別、用途別）
・肺胞蛋白症（PAP）の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・肺胞蛋白症（PAP）の世界市場予測（2019年-2025年）
・肺胞蛋白症（PAP）の地域別市場予測（2019年-2025年）
...

Pulmonary alveolar proteinosis (PAP), also known as pulmonary alveolar phospholipoproteinosis, is a diffuse lung disease characterized by the accumulation of amorphous, periodic acid-Schiff (PAS)-positive lipoproteinaceous material in the distal air spaces.Treatment of PAP depends on the form of PAP and age of a patient with PAP and severity of the disease. WLL is a standard treatment for PAP and the only treatment which has shown improved symptoms and oxygenation in patients. Another treatment of PAP includes using recombinant granulocyte colony stimulating factor (GM-CSF) which is given by nose or with a subcutaneous injection which is not approved yet.
In 2018, the global Pulmonary Alveolar Proteinosis (PAP) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Pulmonary Alveolar Proteinosis (PAP) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pulmonary Alveolar Proteinosis (PAP) development in United States, Europe and China.

The key players covered in this study
Savara
Cleveland Clinic
St. Antonius Hospital Nieuwegein
…

Market segment by Type, the product can be split into
Plasmapheresis
Lung transplant
Others

Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Pulmonary Alveolar Proteinosis (PAP) status, future forecast, growth opportunity, key market and key players.
To present the Pulmonary Alveolar Proteinosis (PAP) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pulmonary Alveolar Proteinosis (PAP) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pulmonary Alveolar Proteinosis (PAP) Market Size Growth Rate by Type (2014-2025)
1.4.2 Plasmapheresis
1.4.3 Lung transplant
1.4.4 Others
1.5 Market by Application
1.5.1 Global Pulmonary Alveolar Proteinosis (PAP) Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Pulmonary Alveolar Proteinosis (PAP) Market Size
2.2 Pulmonary Alveolar Proteinosis (PAP) Growth Trends by Regions
2.2.1 Pulmonary Alveolar Proteinosis (PAP) Market Size by Regions (2014-2025)
2.2.2 Pulmonary Alveolar Proteinosis (PAP) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Pulmonary Alveolar Proteinosis (PAP) Market Size by Manufacturers
3.1.1 Global Pulmonary Alveolar Proteinosis (PAP) Revenue by Manufacturers (2014-2019)
3.1.2 Global Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Pulmonary Alveolar Proteinosis (PAP) Market Concentration Ratio (CR5 and HHI)
3.2 Pulmonary Alveolar Proteinosis (PAP) Key Players Head office and Area Served
3.3 Key Players Pulmonary Alveolar Proteinosis (PAP) Product/Solution/Service
3.4 Date of Enter into Pulmonary Alveolar Proteinosis (PAP) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Pulmonary Alveolar Proteinosis (PAP) Market Size by Type (2014-2019)
4.2 Global Pulmonary Alveolar Proteinosis (PAP) Market Size by Application (2014-2019)

5 United States
5.1 United States Pulmonary Alveolar Proteinosis (PAP) Market Size (2014-2019)
5.2 Pulmonary Alveolar Proteinosis (PAP) Key Players in United States
5.3 United States Pulmonary Alveolar Proteinosis (PAP) Market Size by Type
5.4 United States Pulmonary Alveolar Proteinosis (PAP) Market Size by Application

6 Europe
6.1 Europe Pulmonary Alveolar Proteinosis (PAP) Market Size (2014-2019)
6.2 Pulmonary Alveolar Proteinosis (PAP) Key Players in Europe
6.3 Europe Pulmonary Alveolar Proteinosis (PAP) Market Size by Type
6.4 Europe Pulmonary Alveolar Proteinosis (PAP) Market Size by Application

7 China
7.1 China Pulmonary Alveolar Proteinosis (PAP) Market Size (2014-2019)
7.2 Pulmonary Alveolar Proteinosis (PAP) Key Players in China
7.3 China Pulmonary Alveolar Proteinosis (PAP) Market Size by Type
7.4 China Pulmonary Alveolar Proteinosis (PAP) Market Size by Application

8 Japan
8.1 Japan Pulmonary Alveolar Proteinosis (PAP) Market Size (2014-2019)
8.2 Pulmonary Alveolar Proteinosis (PAP) Key Players in Japan
8.3 Japan Pulmonary Alveolar Proteinosis (PAP) Market Size by Type
8.4 Japan Pulmonary Alveolar Proteinosis (PAP) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Pulmonary Alveolar Proteinosis (PAP) Market Size (2014-2019)
9.2 Pulmonary Alveolar Proteinosis (PAP) Key Players in Southeast Asia
9.3 Southeast Asia Pulmonary Alveolar Proteinosis (PAP) Market Size by Type
9.4 Southeast Asia Pulmonary Alveolar Proteinosis (PAP) Market Size by Application

10 India
10.1 India Pulmonary Alveolar Proteinosis (PAP) Market Size (2014-2019)
10.2 Pulmonary Alveolar Proteinosis (PAP) Key Players in India
10.3 India Pulmonary Alveolar Proteinosis (PAP) Market Size by Type
10.4 India Pulmonary Alveolar Proteinosis (PAP) Market Size by Application

11 Central & South America
11.1 Central & South America Pulmonary Alveolar Proteinosis (PAP) Market Size (2014-2019)
11.2 Pulmonary Alveolar Proteinosis (PAP) Key Players in Central & South America
11.3 Central & South America Pulmonary Alveolar Proteinosis (PAP) Market Size by Type
11.4 Central & South America Pulmonary Alveolar Proteinosis (PAP) Market Size by Application

12 International Players Profiles
12.1 Savara
12.1.1 Savara Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pulmonary Alveolar Proteinosis (PAP) Introduction
12.1.4 Savara Revenue in Pulmonary Alveolar Proteinosis (PAP) Business (2014-2019)
12.1.5 Savara Recent Development
12.2 Cleveland Clinic
12.2.1 Cleveland Clinic Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pulmonary Alveolar Proteinosis (PAP) Introduction
12.2.4 Cleveland Clinic Revenue in Pulmonary Alveolar Proteinosis (PAP) Business (2014-2019)
12.2.5 Cleveland Clinic Recent Development
12.3 St. Antonius Hospital Nieuwegein
12.3.1 St. Antonius Hospital Nieuwegein Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pulmonary Alveolar Proteinosis (PAP) Introduction
12.3.4 St. Antonius Hospital Nieuwegein Revenue in Pulmonary Alveolar Proteinosis (PAP) Business (2014-2019)
12.3.5 St. Antonius Hospital Nieuwegein Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Pulmonary Alveolar Proteinosis (PAP) Key Market Segments
Table Key Players Pulmonary Alveolar Proteinosis (PAP) Covered
Table Global Pulmonary Alveolar Proteinosis (PAP) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Pulmonary Alveolar Proteinosis (PAP) Market Size Market Share by Type 2014-2025
Figure Plasmapheresis Figures
Table Key Players of Plasmapheresis
Figure Lung transplant Figures
Table Key Players of Lung transplant
Figure Others Figures
Table Key Players of Others
Table Global Pulmonary Alveolar Proteinosis (PAP) Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Diagnostic Centers Case Studies
Figure Pulmonary Alveolar Proteinosis (PAP) Report Years Considered
Table Global Pulmonary Alveolar Proteinosis (PAP) Market Size 2014-2025 (Million US$)
Figure Global Pulmonary Alveolar Proteinosis (PAP) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Pulmonary Alveolar Proteinosis (PAP) Market Size by Regions 2014-2025 (Million US$)
Table Global Pulmonary Alveolar Proteinosis (PAP) Market Size by Regions 2014-2019 (Million US$)
Table Global Pulmonary Alveolar Proteinosis (PAP) Market Share by Regions 2014-2019
Figure Global Pulmonary Alveolar Proteinosis (PAP) Market Share by Regions 2014-2019
Figure Global Pulmonary Alveolar Proteinosis (PAP) Market Share by Regions 2019
Table Market Top Trends
Table Global Pulmonary Alveolar Proteinosis (PAP) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Pulmonary Alveolar Proteinosis (PAP) Market Share by Manufacturers (2014-2019)
Figure Global Pulmonary Alveolar Proteinosis (PAP) Market Share by Manufacturers in 2018
Table Global Pulmonary Alveolar Proteinosis (PAP) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Pulmonary Alveolar Proteinosis (PAP) Product/Solution/Service
Table Date of Enter into Pulmonary Alveolar Proteinosis (PAP) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Pulmonary Alveolar Proteinosis (PAP) Market Size by Type (2014-2019) (Million US$)
Table Global Pulmonary Alveolar Proteinosis (PAP) Market Size Share by Type (2014-2019)
Figure Global Pulmonary Alveolar Proteinosis (PAP) Market Size Market Share by Type (2014-2019)
Table Global Pulmonary Alveolar Proteinosis (PAP) Market Size by Application (2014-2019) (Million US$)
Table Global Pulmonary Alveolar Proteinosis (PAP) Market Size Share by Application (2014-2019)
Figure Global Pulmonary Alveolar Proteinosis (PAP) Market Size Market Share by Application (2014-2019)
Figure Global Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Application in 2018
Figure United States Pulmonary Alveolar Proteinosis (PAP) Market Size 2014-2019 (Million US$)
Table United States Key Players Pulmonary Alveolar Proteinosis (PAP) Revenue (2018-2019) (Million US$)
Table United States Key Players Pulmonary Alveolar Proteinosis (PAP) Market Share (2018-2019)
Table United States Pulmonary Alveolar Proteinosis (PAP) Market Size by Type (2014-2019) (Million US$)
Table United States Pulmonary Alveolar Proteinosis (PAP) Market Share by Type (2014-2019)
Table United States Pulmonary Alveolar Proteinosis (PAP) Market Size by Application (2014-2019) (Million US$)
Table United States Pulmonary Alveolar Proteinosis (PAP) Market Share by Application (2014-2019)
Figure Europe Pulmonary Alveolar Proteinosis (PAP) Market Size 2014-2019 (Million US$)
Table Europe Key Players Pulmonary Alveolar Proteinosis (PAP) Revenue (2018-2019) (Million US$)
Table Europe Key Players Pulmonary Alveolar Proteinosis (PAP) Market Share (2018-2019)
Table Europe Pulmonary Alveolar Proteinosis (PAP) Market Size by Type (2014-2019) (Million US$)
Table Europe Pulmonary Alveolar Proteinosis (PAP) Market Share by Type (2014-2019)
Table Europe Pulmonary Alveolar Proteinosis (PAP) Market Size by Application (2014-2019) (Million US$)
Table Europe Pulmonary Alveolar Proteinosis (PAP) Market Share by Application (2014-2019)
Figure China Pulmonary Alveolar Proteinosis (PAP) Market Size 2014-2019 (Million US$)
Table China Key Players Pulmonary Alveolar Proteinosis (PAP) Revenue (2018-2019) (Million US$)
Table China Key Players Pulmonary Alveolar Proteinosis (PAP) Market Share (2018-2019)
Table China Pulmonary Alveolar Proteinosis (PAP) Market Size by Type (2014-20189) (Million US$)
Table China Pulmonary Alveolar Proteinosis (PAP) Market Share by Type (2014-2019)
Table China Pulmonary Alveolar Proteinosis (PAP) Market Size by Application (2014-2019) (Million US$)
Table China Pulmonary Alveolar Proteinosis (PAP) Market Share by Application (2014-2019)
Figure Japan Pulmonary Alveolar Proteinosis (PAP) Market Size 2014-2019 (Million US$)
Table Japan Key Players Pulmonary Alveolar Proteinosis (PAP) Revenue (2018-2019) (Million US$)
Table Japan Key Players Pulmonary Alveolar Proteinosis (PAP) Market Share (2018-2019)
Table Japan Pulmonary Alveolar Proteinosis (PAP) Market Size by Type (2014-2019) (Million US$)
Table Japan Pulmonary Alveolar Proteinosis (PAP) Market Share by Type (2014-2019)
Table Japan Pulmonary Alveolar Proteinosis (PAP) Market Size by Application (2014-2019) (Million US$)
Table Japan Pulmonary Alveolar Proteinosis (PAP) Market Share by Application (2014-2019)
Figure Southeast Asia Pulmonary Alveolar Proteinosis (PAP) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Pulmonary Alveolar Proteinosis (PAP) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Pulmonary Alveolar Proteinosis (PAP) Market Share (2018-2019)
Table Southeast Asia Pulmonary Alveolar Proteinosis (PAP) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Pulmonary Alveolar Proteinosis (PAP) Market Share by Type (2014-2019)
Table Southeast Asia Pulmonary Alveolar Proteinosis (PAP) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Pulmonary Alveolar Proteinosis (PAP) Market Share by Application (2014-2019)
Figure India Pulmonary Alveolar Proteinosis (PAP) Market Size 2014-2019 (Million US$)
Table India Key Players Pulmonary Alveolar Proteinosis (PAP) Revenue (2018-2019) (Million US$)
Table India Key Players Pulmonary Alveolar Proteinosis (PAP) Market Share (2018-2019)
Table India Pulmonary Alveolar Proteinosis (PAP) Market Size by Type (2014-2019) (Million US$)
Table India Pulmonary Alveolar Proteinosis (PAP) Market Share by Type (2014-2019)
Table India Pulmonary Alveolar Proteinosis (PAP) Market Size by Application (2014-2019) (Million US$)
Table India Pulmonary Alveolar Proteinosis (PAP) Market Share by Application (2014-2019)
Figure Central & South America Pulmonary Alveolar Proteinosis (PAP) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Pulmonary Alveolar Proteinosis (PAP) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Pulmonary Alveolar Proteinosis (PAP) Market Share (2018-2019)
Table Central & South America Pulmonary Alveolar Proteinosis (PAP) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Pulmonary Alveolar Proteinosis (PAP) Market Share by Type (2014-2019)
Table Central & South America Pulmonary Alveolar Proteinosis (PAP) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Pulmonary Alveolar Proteinosis (PAP) Market Share by Application (2014-2019)
Table Savara Company Details
Table Savara Revenue in Pulmonary Alveolar Proteinosis (PAP) Business (2014-2019) (Million US$)
Figure Savara Revenue Growth Rate in Pulmonary Alveolar Proteinosis (PAP) Business (2014-2019)
Table Savara Recent Development
Table Cleveland Clinic Company Details
Table Cleveland Clinic Revenue in Pulmonary Alveolar Proteinosis (PAP) Business (2014-2019)(Million US$)
Figure Cleveland Clinic Revenue Growth Rate in Pulmonary Alveolar Proteinosis (PAP) Business (2014-2019)
Table Cleveland Clinic Recent Development
Table St. Antonius Hospital Nieuwegein Company Details
Table St. Antonius Hospital Nieuwegein Revenue in Pulmonary Alveolar Proteinosis (PAP) Business (2014-2019)(Million US$)
Figure St. Antonius Hospital Nieuwegein Revenue Growth Rate in Pulmonary Alveolar Proteinosis (PAP) Business (2014-2019)
Table St. Antonius Hospital Nieuwegein Recent Development
Table Global Pulmonary Alveolar Proteinosis (PAP) Market Size by Regions (Million US$) 2019-2025
Figure Global Pulmonary Alveolar Proteinosis (PAP) Market Size Share by Regions (2019-2025)
Figure Global Pulmonary Alveolar Proteinosis (PAP) Market Size Share by Regions in 2025
Figure United States Pulmonary Alveolar Proteinosis (PAP) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Pulmonary Alveolar Proteinosis (PAP) Market Size Forecast (2019-2025)(Million USD)
Figure China Pulmonary Alveolar Proteinosis (PAP) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Pulmonary Alveolar Proteinosis (PAP) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Pulmonary Alveolar Proteinosis (PAP) Market Size Forecast (2019-2025)(Million USD)
Figure India Pulmonary Alveolar Proteinosis (PAP) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Pulmonary Alveolar Proteinosis (PAP) Market Size Forecast (2019-2025)(Million USD)
Table Global Pulmonary Alveolar Proteinosis (PAP) Market Size by Product (2019-2025) (Million US$)
Figure Global Pulmonary Alveolar Proteinosis (PAP) Market Size by Product (2019-2025)
Figure Global Pulmonary Alveolar Proteinosis (PAP) Market Size by Product in 2025
Table Global Pulmonary Alveolar Proteinosis (PAP) Market Size by Application (2019-2025) (Million US$)
Figure Global Pulmonary Alveolar Proteinosis (PAP) Market Size by Application (2019-2025)
Figure Global Pulmonary Alveolar Proteinosis (PAP) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の肺水腫市場：市場規模・現状・予測

Global Pulmonary Edema Market Size, Status and Forecast 2019-2025
QYR9N7908 2019年6月14日 97Pages
当資料は、肺水腫のグローバル市場について調査・分析したレポートで、種類別（診断、治療）、用途別（病院と診療所、学術機関、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・肺水腫の...

世界の肺水腫の治療市場：市場規模・現状・予測

Global Pulmonary Edema Treatment Market Size, Status and Forecast 2019-2025
QYR9N7909 2019年6月14日 97Pages
当資料は、肺水腫の治療のグローバル市場について調査・分析したレポートで、種類別（診断、治療）、用途別（病院と診療所、学術機関、小売薬局、家庭、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の経カテーテル肺動脈弁市場：市場規模・現状・予測

Global Transcatheter Pulmonary Valve Market Size, Status and Forecast 2019-2025
QYR9N8138 2019年6月14日 99Pages
当資料は、経カテーテル肺動脈弁のグローバル市場について調査・分析したレポートで、種類別（心臓異常、肺閉鎖症、肺狭窄、肺逆流、ファロー四徴学、その他）、用途別（ボストンサイエンティフィックコーポレーション、ブレイルバイオメディカ、ダイレクトフローメディカル、エドワーズライフサイエンス株式会社、Jena...

世界の肺拡散ガス市場2019

Global Lung Diffusion Gas (Pulmonary Diffusion Gas) Sales Market Report 2019
QYR9N2354 2019年6月10日 101Pages
本調査レポートでは、肺拡散ガスの世界市場について調査・分析し、肺拡散ガスのメーカー別販売量、市場シェア分析、種類別販売分析（一酸化炭素、酸素、一酸化炭素、ヘリウム、酸素、一酸化炭素、ネオン、その他）、用途別販売分析（病院、診療所、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、イ...

世界の鎮痛剤デリバリー市場：市場規模・現状・予測

Global Pain Drug Delivery Market Size, Status and Forecast 2019-2025
QYR9N7754 2019年6月14日 94Pages
当資料は、鎮痛剤デリバリーのグローバル市場について調査・分析したレポートで、種類別（経皮ドラッグデリバリーシステム、髄腔内ドラッグデリバリーシステム、その他）、用途別（腫瘍学、神経学的障害、肺疾患、ホルモン障害、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市...

世界の呼吸器および麻酔薬市場：市場規模・現状・予測

Global Respiratory and Anesthesia Disposables Market Size, Status and Forecast 2019-2025
QYR9N7956 2019年6月14日 99Pages
当資料は、呼吸器および麻酔薬のグローバル市場について調査・分析したレポートで、種類別（新生児、小児科、成人）、用途別（慢性閉塞性肺疾患、喘息、睡眠時無呼吸、外科処置、緊急用）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...

世界の光原子時計市場：市場規模・現状・予測

Global Optical Atomic Clocks Market Size, Status and Forecast 2019-2025
QYR9N7711 2019年6月14日 92Pages
当資料は、光原子時計のグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII）、用途別（地上アプリケーション、宇宙アプリケーション）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
...

世界の5Gワイヤレステクノロジ市場：市場規模・現状・予測

Global 5G Wireless Technology Market Size, Status and Forecast 2019-2025
QYR9N8229 2019年6月14日 97Pages
当資料は、5Gワイヤレステクノロジのグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII）、用途別（自動車、携帯電話、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界のロミプロスチム市場：市場規模・現状・予測

Global Romiplostim Market Size, Status and Forecast 2019-2025
QYR9N7982 2019年6月14日 92Pages
当資料は、ロミプロスチムのグローバル市場について調査・分析したレポートで、種類別（250 μg/0.5 mL
、500 μg/1 mL
）、用途別（大人、小児患者）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...

世界のA2Pメッセージング市場：市場規模・現状・予測

Global A2P Messaging Market Size, Status and Forecast 2019-2025
QYR9N8232 2019年6月14日 92Pages
当資料は、A2Pメッセージングのグローバル市場について調査・分析したレポートで、種類別（グレイルートA2P SMS、OTT A2Pメッセージング、その他）、用途別（銀行業、発券業務、健康管理、コンテンツ支払い、オペレータの関与、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、イン...

世界の肺拡散ガス市場2019 Lung Diffusion Gas (Pulmonary Diffusion Gas) is the gas mixture for Lung diffusion testing The global Lung Diffusion Gas (Pulmonary Diffusion Gas) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report stud…
世界の移植診断市場：市場規模・現状・予測 Transplant diagnostic is an administrative as well as clinical tool that helps improve operational efficiency of transplantation technique. Transplant diagnostic aids the patients suffering from cancer in order to improve overall operational efficiency as well as patient care.High prevalence and inc…
世界の肺水腫市場：市場規模・現状・予測 Pulmonary edema or lung congestion is a medical condition characterized by the presence of excessive fluid in the lungs. This may interfere with the exchange of gases leading to respiratory failures.America dominates the global pulmonary edema market owing to a well-developed healthcare sector and h…
世界の肺水腫の治療市場：市場規模・現状・予測 Pulmonary edema refers to the generation and reflux imbalance of tissue fluid in the lung caused by some reasons, so that a large number of tissue fluid in a very short period of time can not be absorbed by the pulmonary lymphatic and pulmonary vein system, from the pulmonary capillary osmosis, accu…
世界の経カテーテル肺動脈弁市場：市場規模・現状・予測 In 2018, the global Transcatheter Pulmonary Valve market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Transcatheter Pulmonary Valve status, future forecast, growth opportunity, key market and key p…